| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 92,57 | 92,83 | 08.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11.25 | MOLNLYCKE: Mölnlycke donates patent to spark innovation in sustainable healthcare | 5 | Cision News | ||
| 05.11.25 | MOLNLYCKE: Mölnlycke establishes first wound care manufacturing site in China | 3 | Cision News | ||
| 05.11.25 | Mölnlycke Health Care: Mölnlycke establishes first wound care manufacturing site in China | 475 | PR Newswire | CHANGSHU, China and GOTHENBURG, Sweden, Nov. 5, 2025 /PRNewswire/ -- Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement... ► Artikel lesen | |
| 15.10.25 | MOLNLYCKE: Mölnlycke Health Care's global headquarters ranked number one workplace in Sweden and top 20 globally in Leesman workplace experience survey | 2 | Cision News | ||
| 23.09.25 | MOLNLYCKE: Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine | 2 | Cision News | ||
| MOLNLYCKE Aktie jetzt für 0€ handeln | |||||
| 17.09.25 | MOLNLYCKE: High burnout among operating room staff poses significant risk to patient safety-new review reveals | 1 | Cision News | ||
| 21.08.25 | GTU und Mölnlycke Health Care beziehen Düsseldorfer Euref-Campus | 8 | DEAL-Magazin | ||
| 21.08.25 | MOLNLYCKE: Mölnlycke awarded second consecutive EcoVadis Platinum medal for sustainability performance | 1 | Cision News | ||
| 19.08.25 | MOLNLYCKE: New study highlights the importance of double gloving with indicator systems | 2 | Cision News | ||
| 07.04.25 | Mölnlycke Supports Surgical Gloving Best Practice as 2025 Revised AORN Recommended Guidelines for Perioperative Practice are Presented | 680 | Business Wire | A poster reviewing updates to the Association of periOperative Registered Nurses (AORN) Guidelines for Perioperative Practice regarding surgical gloving was presented today at the AORN Global Surgical... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 85,28 | -0,15 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| M1 KLINIKEN | 18,600 | -0,53 % | M1 Kliniken: Zimmnau in den Vorstand berufen | M1 Kliniken erweitert den Vorstand: Einer Meldung des Berliner Unternehmens vom Donnerstag zufolge hat man "Katharina Zimmnau mit Wirkung zum 10.12.2025 in den Vorstand der M1 Kliniken AG berufen".... ► Artikel lesen | |
| MCKESSON | 694,00 | -1,59 % | McKesson Builds Earnings Momentum on Specialty and Automation | ||
| MOLINA HEALTHCARE | 158,50 | +4,97 % | Earnings Preview: What To Expect From Molina Healthcare's Report | ||
| LIMES SCHLOSSKLINIKEN | 374,00 | +0,54 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.12.2025 / 11:21... ► Artikel lesen | |
| LANTHEUS | 59,30 | -0,17 % | Lantheus Holdings, Inc.: Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies | BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians... ► Artikel lesen | |
| LEMAITRE VASCULAR | 72,00 | 0,00 % | Dividendenbekanntmachungen (20.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIENT INC US0193301092 0,03 USD 0,0259 EUR APPLIED MATERIALS INC US0382221051 0,46 USD 0,3986 EUR APPLIED MATERIALS INC CDR CA03822G1046 0... ► Artikel lesen | |
| MERIT MEDICAL SYSTEMS | 80,00 | +2,56 % | Merit Medical Systems, Inc.: Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial | The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty... ► Artikel lesen | |
| NIPRO | 7,850 | -1,26 % | GHIT Fund: Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others | TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of... ► Artikel lesen | |
| MEDCAP | 50,60 | -0,39 % | MEDCAP AB: Strong organic and acquired growth; EBITA increased by 32% | ||
| NORDHEALTH | 2,960 | 0,00 % | Nordhealth AS: Financial calendar | ||
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen |